Standout Papers
Citation Impact
Citing Papers
Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
2006
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
2012
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease
2017
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
2013
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
2016
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
2015
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
A Test in Context: Lipoprotein(a)
2017
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/β-lactone is not a specific inhibitor of the proteasome
2000 StandoutNobel
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
2013
Sleep-disordered breathing and stroke
2003
Rapid rule out of acute myocardial infarction: novel biomarker-based strategies
2016
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
2012
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study
2006
Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy
2011
The Prospective Association of Serum Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-1 Levels with All Cause and Cardiovascular Disease Mortality in Older Adults: The Rancho Bernardo Study
2004
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
Discrimination of patients with type 2 myocardial infarction
2017
Nucleotide signalling during inflammation
2014 StandoutNature
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
2008
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
2014
Toward the quiescent coronary plaque
1993
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
2009
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
2006
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
The changing landscape of atherosclerosis
2021 StandoutNature
Physical Exertion as a Trigger of Acute Myocardial Infarction
1993
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
2012
Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups
2014
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Severe Sepsis and Septic Shock
2013 Standout
Insulin-like Growth Factors and Subsequent Risk of Mortality in the United States
2007
Ischemia Detected on Continuous Electrocardiography After Acute Coronary Syndrome
2009
Inflammatory bio‐markers and cardiovascular risk prediction
2002
Update on acute coronary syndromes: the pathologists' view
2012
Cardiac troponin level elevations not related to acute coronary syndromes
2013
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments
2015
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
2013
Triglycerides and cardiovascular disease
2014
How to use high-sensitivity cardiac troponins in acute cardiac care
2012
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis
2016
Rationale and current perspective for early rhythm control therapy in atrial fibrillation
2011
Day–Night Pattern of Sudden Death in Obstructive Sleep Apnea
2005
The contribution of thrombosis to the clinical expression of coronary atherosclerosis
1996
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Reduction of Myocardial Infarct Size with Ischemic “Conditioning”
2013
Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook
2015
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
2014
Genetic predisposition to respiratory infection and sepsis
2011
Postprandial hypertriglyceridemia as a coronary risk factor
2014
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
2009
Atherosclerosis
2019 Standout
Elevated Cardiac Troponin T in Patients With Skeletal Myopathies
2018
Triggering and hourly variation of onset of arterial thrombosis
1992
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
2008
Structural and Functional Alteration of Blood Vessels Caused by Cigarette Smoking: An Overview of Molecular Mechanisms
2007
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease
2012
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
2013
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
2012
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients
2013
Standardized End Point Definitions for Coronary Intervention Trials
2018
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
2016
Field-resolved infrared spectroscopy of biological systems
2020 StandoutNatureNobel
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Nonvalidation of Reported Genetic Risk Factors for Acute Coronary Syndrome in a Large-Scale Replication Study
2007
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
2014
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
2013
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction
2017
Frailty in elderly people
2013 Standout
Cardiomyocyte Regeneration from Circulating Bone Marrow Cells in Mice
2003
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
2016
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study
2008
Age, treatment, and outcomes in high-risk non‐ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Revisiting biomarker discovery by plasma proteomics
2017
In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association
2014
Cerebrovascular disease and sleep
2004
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine
2018
Inflammation as a Risk Factor for Atrial Fibrillation
2003 Standout
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
2016
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The Preconditioning Phenomenon
2000
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force
2016
Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population
2013
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Hypertriglyceridemia in the Genomic Era: A New Paradigm
2015
Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice
2003
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.
1990
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
2016
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects
2011
Guidelines for the Primary Prevention of Stroke
2014 Standout
Sudden cardiac death. Support for a role of triggering in causation.
1993
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Statins for the primary prevention of cardiovascular disease
2013
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
1996
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
2018
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
2001
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
2016
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Vasculoprotective and Cardioprotective Mechanisms of Angiotensin‐Converting Enzyme Inhibition: The Homeostatic Balance Between Angiotensin II and Nitric Oxide
1997
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
1993
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans
2017
Coronary Plaque Disruption
1995 Standout
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
Role of C-Reactive Protein in Cardiovascular Disease
2003
Evidence for Antigen-Driven T-Cell Response in Unstable Angina
2000
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
2012
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Lipoprotein(a): resurrected by genetics
2012
High-sensitivity cardiac troponin assays and unstable angina
2016
Migraine and cardiovascular disease in women and the role of aspirin: Subgroup analyses in the Women’s Health Study
2011
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
2016
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Felicita Andreotti being referenced
Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)
2016
Meta-Analysis of Time-Related Benefits of Statin Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
2014
Preinfarction Angina as a Predictor of More Rapid Coronary Thrombolysis in Patients with Acute Myocardial Infarction
1996
Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
2005
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patients
2005
Erythropoietin in heart and vessels: focus on transcription and signalling pathways
2008
Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies
2002
Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes
2007
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty
1993
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
2013
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease
2005
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function
2005
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
1988
Lipoprotein(a) as a cardiovascular risk factor: current status
2010
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction
2001
Aspirin Therapy in Primary Cardiovascular Disease Prevention
2014
Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies
2011
Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction
1990
Temporal Relation Between Ischemic Episodes and Activation of the Coagulation System in Unstable Angina
1996
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013
Insulin-Like Growth Factor-1 as a Vascular Protective Factor
2004
Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin
1999
Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
1994
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
Age dependence of ischaemic heart syndromes and the contribution of haemostatic deviations
1992
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The −174G/C Interleukin-6 Polymorphism Influences Postoperative Interleukin-6 Levels and Postoperative Atrial Fibrillation. Is Atrial Fibrillation an Inflammatory Complication?
2003
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
2013